Westlake Village BioPartners logo

Westlake Village BioPartners

North America, California, United States, Westlake Village

Description

Westlake Village BioPartners is venture capital firm focused on incubating and building life sciences companies.

Investor Profile

Westlake Village BioPartners has made 24 investments, with 3 in the past 12 months and 33% as lead.

Stage Focus

  • Series B (38%)
  • Series A (33%)
  • Series C (17%)
  • Convertible Note (4%)
  • Series Unknown (4%)
  • Seed (4%)

Country Focus

  • United States (92%)
  • United Kingdom (4%)
  • Canada (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Life Science
  • Biopharma
  • Pharmaceutical
  • Cloud Computing
  • Oncology
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Westlake Village BioPartners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
Access Biotechnology
North America, New York, United States, New York
Co-Investments: 3
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 5
CA
North America, Massachusetts, United States, Boston
Co-Investments: 4
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 7
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 3
Parker Institute for Cancer Immunotherapy
North America, California, United States, San Francisco
Co-Investments: 4
RTW Investments
North America, New York, United States, New York
Co-Investments: 3
CH
North America, New York, United States, New York
Co-Investments: 6
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 4

What are some of recent deals done by Westlake Village BioPartners?

Latigo Biotherapeutics

Thousand Oaks, California, United States

Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.

BiotechnologyHealth CareMedicalTherapeutics
Series BMar 17, 2025
Amount Raised: $150,000,000
Borealis Biosciences

Vancouver, British Columbia, Canada

Borealis Biosciences is a company in the field of next-generation RNA medicines.

BiotechnologyLife ScienceMedical
Series ADec 19, 2024
Amount Raised: $30,000,000
ArsenalBio

South San Francisco, California, United States

ArsenalBio is a programmable cell therapy company that offers CAR T-cell therapies for solid tumors.

BiotechnologyCloud ComputingLife ScienceMedical
Series CSep 4, 2024
Amount Raised: $325,000,000
Latigo Biotherapeutics

Thousand Oaks, California, United States

Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain.

Health CareMedicalTherapeutics
Series AFeb 14, 2024
Amount Raised: $135,000,000
Star Therapeutics

South San Francisco, California, United States

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

Health CareMedicalTherapeutics
Series CSep 5, 2023
Amount Raised: $90,000,000
Kyverna Therapeutics

Berkeley, California, United States

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

BiotechnologyLife ScienceTherapeutics
Series BAug 3, 2023
Amount Raised: $60,000,000
Kate Therapeutics

San Diego, California, United States

Kate Therapeutics is a patient-focused biotechnology company.

BiotechnologyHealth CareTherapeutics
Series AJun 8, 2023
Amount Raised: $51,000,000
Akamis Bio

Abingdon, Oxfordshire, United Kingdom

Akamis Bio is a clinical-stage oncology company.

BiotechnologyHealth CareOncologyTherapeutics
Convertible NoteJan 5, 2023
Amount Raised: $30,000,000
Dantari

Thousand Oaks, California, United States

Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system.

Life Science
Series ADec 8, 2022
Amount Raised: $47,000,000
ACELYRIN

Los Angeles, California, United States

ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.

BiopharmaBiotechnologyHealth Care
Series CSep 13, 2022
Amount Raised: $300,000,000